Estradiol reverses renal injury in Alb/TGF-β1 transgenic mice

Kidney International

Volumn 66, Issue 6, 2004, Pages 2148-2154

  Blush, Joel ^a   Lei, Jun ^a   Ju, Wenjun ^a   Silbiger, Sharon ^a   Pullman, James ^a   Neugarten, Joel ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Chronic renal failure; Collagen; Estradiol; Glomerulosclerosis; TGF 1

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 4; ESTRADIOL; PLACEBO; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA; TGFB1 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CAPILLARY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE COURSE; GLOMERULOSCLEROSIS; KIDNEY PARENCHYMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; SEX DIFFERENCE; SUSTAINED DRUG RELEASE; TRANSGENIC MOUSE; URINALYSIS; ANIMAL; APOPTOSIS; C57BL MOUSE; CBA MOUSE; DELAYED RELEASE FORMULATION; DRUG IMPLANT; FOCAL GLOMERULOSCLEROSIS; GENETICS; GLOMERULUS; IN VITRO STUDY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; APOPTOSIS; COLLAGEN TYPE I; DELAYED-ACTION PREPARATIONS; DRUG IMPLANTS; ESTRADIOL; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; KIDNEY GLOMERULUS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; PROTEINURIA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 21644448251     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.66005.x     Document Type: Article

References (39)

1. SILBIGER S, NEUGARTEN J: The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 25:515-533, 1995
2. SILBIGER S, NEUGARTEN J: The role of gender in the progression of renal disease. Adv Ren Replace Ther 10:3-14, 2003
3. DATTA PK, BLAKE MC, MOSES HL: Regulation of plasminogen activator inhibitor-1 expression by transforming growth factor-β-induced physical and functional interactions between Smads and Sp1. J Biol Chem 275:40014-40019, 2000
4. PONCELET AC, SCHNAPER HW: Sp1 and Smad proteins cooperate to mediate transforming growth factor-β1-induced α2(I) collagen expression in human glomerular mesangial cells. J Biol Chem 276:6983-6992, 2001
5. INAGAKI Y, NEMOTO T, NAKAO A, et al: Interaction between GC box binding factors and Smad proteins modulates cell lineage-specific α2(I) collagen gene transcription. J Biol Chem 276:16573-16579, 2001
6. ZHANG W, OU J, INAGAKI Y, et al: Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor β1 stimulation of α2(I)-collagen (COL1A2) transcription. J Biol Chem 275:39237-39245, 2000
7. PARDALI K, KURISAKI A, MOREN A, et al: Role of Smad proteins and transcription factor Sp1 in p21 regulation by transforming growth factor-β. J Biol Chem 275:29244-29256, 2000
8. SHEN X, HU PPC, LIBERATI NT, et al: TGF-β-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein. Mol Biol Cell 9:3309-3319, 1998
9. GHOSH AK, YUAN W, MORI Y, VARGA J: Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivators. Oncogene 19:3546-3555, 2001
10. ALLENDE JE, ALLENDE CC: Protein kinase CK2: An enzyme with multiple substrates and a puzzling regulation. FASEB J 9:313-323, 1995
11. GUERRA B, BOLDYREFF B, SARNO S, et al: CK2: A protein kinase in need of control. Pharmacol Ther 82:303-313, 1999
12. ZDUNEK M, SILBIGER SR, LEI J, NEUGARTEN J: Protein kinase CK2 mediates TGF-beta 1-stimulated type IV collagen gene transcription and its reversal by estradiol. Kidney Int 60:2097-2108, 2001
13. SRIVASTAVA S, WEITZMANN MN, KIMBLE RB, et al: Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phoshorylation of Egr-1 and its interaction with Sp1. J Clin Invest 102:1850-1859, 1998
14. NEGULESCU O, BOGNAR I, LEI J, et al: Estradiol reverses TGF-β1-induced mesangial cell apoptosis by a protein kinase CK 2-dependent mechanism. Kidney Int 62:1989-1998, 2002
15. MOZES MM, BOTTINGER EP, JACOT TA, KOPP JB: Renal expression of fibrotic matrix proteins and of transforming growth factor-β (TGF-β) Isoforms in TGF-β transgenic mice. J Am Soc Nephrol 10:271-280, 1999
16. KOPP JB, FACTOR VM, MOZES M, et al: Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab Invest 74:991-1003, 1996
17. SANDERSON N, FACTOR V, NAGY P, et al: Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 92:2572-2576, 1995
18. ENGVALL E, PERLMAN P: Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobin G. Immunochemistry 8:871-874, 1971
19. NEUGARTEN J, FEINER H, SCHACHT RG, et al: Aggravation of experimental glomerulonephritis by superimposed clip hypertension. Kidney Int 22:257-263, 1982
20. NEUGARTEN J, FEINER HD, SCHACHT RG, BALDWIN DS: Amelioration of experimental glomerulonephritis by dietary protein restriction. Kidney Int 24:595-601, 1983
21. NEUGARTEN J, KAMINETSKY B, FEINER H, et al: Nephrotoxic serum nephritis with hypertension: Amelioration by antihypertensive therapy. Kidney Int 28:135-139, 1985
22. BANK N, MILITZA K, PRAVIN SC, et al: Inhibition of nitric oxide synthase ameliorates cellular injury in sickle cell mouse kidneys. Kidney Int 58:82-89, 2000
23. HELLER-HARRISON RA, CZECH MP: Enhanced casein kinase II activity in COS-1 cells upon overexpression of either its catalytic or noncatalytic subunit. J Biol Chem 266:14435-14439, 1991
24. KUENZEL EA, KREBS EG: A synthetic peptide substrate specific for casein kinase II. Proc Natl Acad Sci USA 82:737-741, 1985
25. CIESLIK K, LEE C-M, TANG J-L, WU KK: Transcriptional regulation of endothelial nitric-oxide synthase by an interaction between casein kinase 2 and protein phosphatase 2 A. J Biol Chem 274:34669-34675, 1999
26. NEUGARTEN J, ACHARYA A, SILBIGER SR: The effect of gender on the progression of non-diabetic renal disease: A meta-analysis. J Am Soc Nephrol 11:319-329, 2000
27. SILBIGER S, LEI J, ZIYADEH FN, NEUGARTEN J: Estradiol reverses TGF-β1-stimulated type IV collagen gene transcription in murine mesangial cells. Am J Physiol 43:F1113-F1118, 1998
28. 15INK4B through an Sp1 consensus site. J Biol Chem 270:26750-26753, 1995
29. DATTO MB, YU Y, WANG X-F: Functional analysis of the transforming growth factor β responsive elements in the WAF1/Cip1/p21 promoter. J Biol Chem 270:28623-28628, 1995
30. ITO E, IWAHASHI Y, YANAGISAWA Y, et al: Two short sequences have positive effects on the human p27Kip1 gene transcription. Gene 228:93-100, 1999
31. JIMENEZ SA, VARGA J, OLSEN A, et al: Functional analysis of human α1(I) procollagen gene promoter. Differential activity in collagen-producing and -nonproducing cells and response to transforming growth factor β1. J Biol Chem 269:12684-12691, 1994
32. PARK I-K, LYU M-A, YEO S-J, et al: Sp1 mediates constitutive and transforming growth factor β-inducible expression of urokinase type plasminogen activator receptor gene in human monocyte-like U937 cells. Biochem Biophys Acta 1490:302-310, 2000
33. SELMANOFF MK, GOLDMAN BD, GINSBURG BE: Developmental changes in serum leutinizing hormone, follicle stimulating hormone and androgen levels in males of two inbred mouse strains. Endocrinology 100:122-127, 1977
34. ELEFTHERIOU BE, LUCAS LA: Age-related changes in testes, seminal vesicles and plasma testosterone levels in male mice. Gerontologia 20:231-238, 1974
35. JOLES JA, VAN GOOR H, KOOMANS A: Estrogen induces glomerulosclerosis in analbuminemic rats. Kidney Int 53:862-868, 1998
36. STEVENSON FT, WHEELDON CM, GADES MD, et al: Estrogen worsens incipient hypertriglyceridemic glomerular injury in the obese Zucker rat. Kidney Int 57:1927-1935, 2000
37. KULLER LH: Hormone replacement therapy and risk of cardiovascular disease: Implications of the results of the Women's Health Initiative. Arterioscler Thromb Vasc Biol 23:11-16, 2003
38. HODIS HN, MACK WJ, LOBO RA, et al: Estrogen in the prevention of atherosclerosis. Ann Intern Med 135:939-953, 2001
39. HERRINGTON DM, REBOUSSIN DM, BROSNIHAN KB, et al: Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 343:522-529, 2000